Replies to post #8039 on Tenax Therapeutics Inc (TENX)

[Rogerthat1]

$TENX "We believe that the combination of the unique HELP Study patient population, innovative weekly 24-hour dosing, unique home-based site of administration, and novel findings of efficacy and safety in PH-HFpEF patients represent unique discoveries and significant intellectual property. These discoveries form the basis for a US patent application that we have filed.

Additionally, our Board of Directors continues to review strategic alternatives focused on maximizing stockholder value. "

[Rogerthat1]

$TENX
"Based on our working capital at December 31, 2019 and the net proceeds from our March 2020 offering, we believe we have sufficient capital on hand to continue to fund operations through the third quarter of calendar year 2020."

From 10K filed ah today https://www.sec.gov/Archives/edgar/data/34956/000165495420003498/tenx_10k.htm